Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	1/21/2005 11:00:31 PM
	Read Replies (1) of 4974

Tercica Files Registration Statement for Follow-On Offering Friday January 21, 7:05 pm ET SOUTH SAN FRANCISCO, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Tercica, Inc. (Nasdaq: TRCA - News) today announced that it has filed a registration statement with the Securities and Exchange Commission covering a proposed offering of 6,000,000 shares of its common stock. All of the shares are being offered by Tercica. The offering will be made only by means of a prospectus. Lehman Brothers will act as the sole book running manager of the offering with SG Cowen serving as joint lead manager. Robert W. Baird & Co., Friedman, Billings, Ramsey and Harris Nesbitt will act as co-managers. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next